Epicelya Therapeutics is a precision medicine company pioneering the future of genetic healthcare. Our mission is to develop mRNA-based therapeutics that target diseases previously considered "undruggable". Through our innovative precision epigenetics and targeted cell elimination platforms, we aim to address the most challenging conditions, especially where traditional treatments have failed or lack suitable targets, with a focus on oncology and age-related diseases.
Based in Basel, Switzerland’s pharma-biotech hub, we are at the heart of scientific innovation. Learn more at www.epicelya.com.
Company Details
- Employees
- 1
- Address
- The Most Challenging Conditions
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.epicelya.com
- Keywords
- Hunter Biodiscovery.
Epicelya Therapeutics Ag Questions
Epicelya Therapeutics Ag's website is http://www.epicelya.com
Epicelya Therapeutics Ag's LinkedIn profile is https://www.linkedin.com/company/epicelya-therapeutics-ag
Epicelya Therapeutics Ag has
1 employees.
View email and phone details for 1
employees at Epicelya Therapeutics Ag.
Epicelya Therapeutics Ag's industry is
Biotechnology Research
Epicelya Therapeutics Ag's top competitors are
Xenopat,
Red Ridge Bio,
Cureomics Ag,
Tolremo Therapeutics,
Senostic Gmbh,
Scholengroep Carmel Hengelo,
Hunter Biodiscovery,
Blackway Biosciences Ag,
Amylon Therapeutics,
Paicon.
Epicelya Therapeutics Ag's categories are Biotechnology Research
